Creutzfeldt-Jakob disease presenting as hyperparathyroidism and generalized tonic status epilepticus

Clinical EEG and Neuroscience

Volumn 38, Issue 4, 2007, Pages 203-206

  Karatas, Hulya ^a   Dericioglu, Nese ^a   Kursun, Oguzhan ^a   Saygi, Serap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Creutzfeldt Jakob disease; Diffusion weighted MRI; Electroencephalography; Generalized status epilepticus; Hypercalcemia; Hyperparathyroidism; Prion disease

Indexed keywords

DIAZEPAM; ISOFLURANE; MIDAZOLAM; PHENOBARBITAL; VALPROIC ACID;

AGED; ANOREXIA; ANOSOGNOSIA; APATHY; ARTICLE; ATAXIA; BRAIN CORTEX; BRAIN REGION; CALCIUM BLOOD LEVEL; CASE REPORT; CAUDATE NUCLEUS; CEREBELLUM; CEREBRAL BLINDNESS; CLINICAL FEATURE; COLOR VISION DEFECT; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISORIENTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FATIGUE; FEMALE; FOLLOW UP; GENERALIZED EPILEPSY; HEART PALPITATION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; MENTAL DETERIORATION; METABOLIC ENCEPHALOPATHY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NODULAR GOITER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PARATHYROIDECTOMY; PARESTHESIA; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; TONIC SEIZURE; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EID: 35948931448     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940703800404     Document Type: Article

References (17)

1. Belay E, Maddox RA, Gambetti P, Schonberger LB. Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology 2003; 60: 176-181.
2. Korezyn AD. Prion diseases. Current Opinions in Neurology 1997; 10: 273-281.
3. Levy S, Chiappa K, Burke C, Young R. Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol 1986; 3: 1-21.
4. Smith SJ, Kocen RS. A Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1998; 5: 120-123.
5. Bertolucci PH, Malheriros SF. Hyperparathyroidism simulating Creutzfeldt-Jakob disease. Arq Neuropsiquatr 1990; 48(2): 245-249.
6. Goto F, Kano S, Ogawa K. Creutzfeldt-Jakob disease presenting hyperparathyroidism. Auris Nasus Larynx 2000; 27(3): 281-283.
7. Johnson RT, Gibbs CJ. Creutzfeldt - Jakob disease and related transmisible spongiform encephalopathies. N Engl J Med 1998; 31: 1994-2004.
8. Hsich G, Kenney K, Gibbs CJ Jr, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-930.
9. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.
10. Steinhoff BJ, Racker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-166.
11. Yang MD, Steven PB, Keith JN, William P, Paul LP, Robert ES. Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature. AJNR Am J Neuroradiol 2002; 23: 550-556.
12. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217: 331-345.
13. Concerted Action of the EU. Surveillance of Creutzfeldt-Jakob disease in the European Community. Minutes of the second meeting in Rome, July 3, 1993, and the third meeting in Paris, April 29-30, 1994.
14. Flöel A, Reilmann R, Frese A, Lüdeman P. Anticonvulsants for Creutzfeldt-Jakob disease? Lancet 2003; 361: 224.
15. Kümpfel T, Lechner C, Auer D, Kraft E, Lydtin H, Trenkwalder C. Non-convulsive status epilepticus with marked neuropsychiatric manifestations and MRI changes after treatment of hypercalcemia. Acta Neurol Scand 2000; 102: 337-339.
16. Zanusso G, Ferrari S, Cardone F. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 348(8): 711-719.
17. Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. 8th ed. 2003: 241.